Zhengye Biotechnology Holding Limited (ZYBT)
NASDAQ: ZYBT · Real-Time Price · USD
4.270
-0.060 (-1.39%)
Feb 11, 2025, 4:00 PM EST - Market closed
ZYBT Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 |
---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 7.19 | 15.07 | 9.75 | 6.28 |
Short-Term Investments | 1.33 | 1.22 | - | - |
Cash & Short-Term Investments | 8.52 | 16.3 | 9.75 | 6.28 |
Cash Growth | -63.81% | 67.22% | 55.09% | - |
Accounts Receivable | 88.76 | 97.38 | 133.58 | 101.47 |
Other Receivables | 2.89 | 2.04 | 0.67 | 0.72 |
Receivables | 91.65 | 99.42 | 134.25 | 102.19 |
Inventory | 65.19 | 58.3 | 55.42 | 43.62 |
Restricted Cash | - | 12.11 | - | - |
Other Current Assets | 13.7 | 7.55 | 2.43 | 1.71 |
Total Current Assets | 189.73 | 205.59 | 214.31 | 164.94 |
Property, Plant & Equipment | 254.34 | 263.31 | 275.23 | 246.41 |
Other Intangible Assets | 24.62 | 24.48 | 27.9 | 20.75 |
Other Long-Term Assets | 18.92 | 6.5 | 2.23 | 13.17 |
Total Assets | 487.61 | 499.89 | 519.67 | 445.28 |
Accounts Payable | 41.64 | 45.66 | 79.28 | 77.57 |
Accrued Expenses | 4.4 | 0.54 | 0.57 | 0.6 |
Short-Term Debt | 79.9 | 79.86 | 54.89 | 30 |
Current Income Taxes Payable | - | 2.3 | 10 | 6.81 |
Current Unearned Revenue | 3.22 | 3.99 | 4.7 | 4.28 |
Other Current Liabilities | 0.78 | 17.9 | 2.79 | 6.37 |
Total Current Liabilities | 137.43 | 150.23 | 152.23 | 125.63 |
Long-Term Debt | - | 9.99 | 9.99 | - |
Other Long-Term Liabilities | 0.39 | 0.39 | 0.59 | 0.82 |
Total Liabilities | 137.82 | 160.62 | 162.81 | 126.44 |
Common Stock | 0.01 | 0.01 | 0.01 | 0.01 |
Additional Paid-In Capital | 203.15 | 203.15 | 203.15 | 203.15 |
Retained Earnings | 78.5 | 69.69 | 93.34 | 64.32 |
Total Common Equity | 281.66 | 272.85 | 296.5 | 267.47 |
Minority Interest | 68.14 | 66.42 | 60.37 | 51.36 |
Shareholders' Equity | 349.8 | 339.27 | 356.87 | 318.84 |
Total Liabilities & Equity | 487.61 | 499.89 | 519.67 | 445.28 |
Total Debt | 87.39 | 89.85 | 64.88 | 30 |
Net Cash (Debt) | -78.87 | -73.55 | -55.13 | -23.72 |
Net Cash Per Share | -1.73 | -1.61 | -1.21 | -0.52 |
Filing Date Shares Outstanding | 45.67 | 45.67 | 45.67 | 45.67 |
Total Common Shares Outstanding | 45.67 | 45.67 | 45.67 | 45.67 |
Working Capital | 52.31 | 55.36 | 62.08 | 39.32 |
Book Value Per Share | 6.17 | 5.97 | 6.49 | 5.86 |
Tangible Book Value | 257.04 | 248.37 | 268.59 | 246.72 |
Tangible Book Value Per Share | 5.63 | 5.44 | 5.88 | 5.40 |
Buildings | 197.19 | 197.19 | 119.79 | 166.9 |
Machinery | 150.87 | 151.04 | 146.74 | 118 |
Construction In Progress | 8.25 | 7.62 | 82.06 | 52.76 |
Source: S&P Capital IQ. Standard template. Financial Sources.